Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Catalent Inc (NY: CTLT ) 55.85 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, Apr 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 55.85 Bid (Size) 55.55 (1) Ask (Size) 55.85 (3) Prev. Close 55.85 Today's Range 55.85 - 55.85 52wk Range 31.80 - 60.20 Shares Outstanding 170,341,553 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Robbins LLP Reminds Stockholders it is Investigating the Acquisition of Catalent, Inc. (CTLT) April 17, 2024 From Robbins LLP Via Business Wire Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating April 12, 2024 BMO's coverage of Novo Nordisk, spotlighting its groundbreaking advancements in weight loss and diabetes drugs. Analysts foresee Novo and Eli Lilly maintaining dominance in the obesity market, fueled... Via Benzinga Performance YTD +23.97% +23.97% 1 Month -0.96% -0.96% 3 Month +5.30% +5.30% 6 Month +62.40% +62.40% 1 Year +11.43% +11.43% More News Read More Robbins LLP is Investigating the Acquisition of Catalent, Inc. (CTLT) by Novo Holdings April 10, 2024 From Robbins LLP Via GlobeNewswire Beyond The Numbers: 6 Analysts Discuss Catalent Stock April 04, 2024 Via Benzinga (CTLT) - Analyzing Catalent's Short Interest February 28, 2024 Via Benzinga In-Depth Examination Of 5 Analyst Recommendations For Catalent February 20, 2024 Via Benzinga Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics? March 26, 2024 Via The Motley Fool Week In Review: Three Multinationals Plan Investments In Southeast Asia Facilities March 23, 2024 Via Talk Markets Did Novo Nordisk Just Get a Jump on Eli Lilly? March 19, 2024 Via The Motley Fool Exposures Product Safety The Top 3 Pharma Stocks to Buy in March2024 March 09, 2024 Via InvestorPlace Novo Nordisk Sets Timeframe For Its Next-Gen Experimental Obesity Drug March 08, 2024 Via Benzinga Catalent Publishes Fifth Annual Corporate Responsibility Report, Highlighting Progress and Reinforcing Long-Term Commitment March 07, 2024 From Catalent, Inc. Via Business Wire Escalating Demand for Obesity Drugs Creates Time-Sensitive Race for Eli Lilly, Novo Nordisk March 06, 2024 Via Benzinga Prediction: Eli Lilly and Novo Nordisk Stock Could Just be Getting Started. Here's Why March 05, 2024 Via The Motley Fool Record-High S&P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla March 01, 2024 Via Benzinga Topics ETFs Stocks Exposures US Equities Top Stocks Not Named Nvidia You Need To Know About In 2024: Here's What Investors Think About Them (Wall Street Vs. Reddit) February 29, 2024 Via Benzinga Eli Lilly, Novo Nordisk's Strategies Against New Weight-Loss Drug Competitors February 26, 2024 Via Benzinga CATALENT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Catalent, Inc. - CTLT February 16, 2024 From Kahn Swick & Foti, LLC Via Business Wire S&P 500's surge to new highs: Bull trap hiding in plain sight? February 15, 2024 Via MarketBeat Topics ETFs Economy Stocks Exposures Interest Rates US Equities Nearly Half Of S&P 500 Stocks Trade Below 50-Day Moving Average: Which One Is The Cheapest? February 14, 2024 Via Benzinga Topics Stocks Exposures US Equities Novo Nordisk, Eli Lilly Stride To Boost Supply Shortage For Newly Found Holy Grail Of Miraculous Weight Loss Drugs February 12, 2024 Via Benzinga Novo Nordisk Is Scaling a Barrier to Growth. Should You Buy Its Stock Now? February 11, 2024 Via The Motley Fool Novo Nordisk Just Gave Investors $16.5 Billion More Reasons to Get Excited February 10, 2024 Via The Motley Fool Catalent, Inc. Reports Second Quarter Fiscal 2024 Results February 09, 2024 From Catalent, Inc. Via Business Wire US Stocks Set To Open Higher, Finish Week Stronger Amid Mixed Earnings: Analyst Sees Another Leg-Up Ahead Of Historically Weak March February 09, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
